Veritas Asset Management’s Medtronic MDT Stock Holding History

Veritas Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.56M	Sell	96,690 -66,018	-41%	-$5.33M	0.14%	20
2026 Q1	$14.1M	Sell	162,708 -18,299	-10%	-$1.75M	0.24%	17
2025 Q4	$17.4M	Hold	181,007	–	–	0.18%	19
2025 Q3	$17.2M	Hold	181,007	–	–	0.18%	20
2025 Q2	$15.8M	Hold	181,007	–	–	0.16%	19
2025 Q1	$16.3M	Hold	181,007	–	–	0.16%	20
2024 Q4	$14.5M	Hold	181,007	–	–	0.13%	20
2024 Q3	$16.3M	Hold	181,007	–	–	0.12%	21
2024 Q2	$14.2M	Hold	181,007	–	–	0.11%	20
2024 Q1	$15.8M	Hold	181,007	–	–	0.11%	20
2023 Q4	$14.9M	Buy	181,007 +44,236	+32%	+$3.37M	0.11%	21
2023 Q3	$10.7M	Hold	136,771	–	–	0.08%	27
2023 Q2	$12M	Hold	136,771	–	–	0.08%	27
2023 Q1	$11M	Buy	136,771 +27,510	+25%	+$2.24M	0.08%	25
2022 Q4	$8.49M	Sell	109,261 -2,877	-3%	-$233K	0.07%	26
2022 Q3	$9.05M	Sell	112,138 -9,808	-8%	-$881K	0.07%	28
2022 Q2	$10.9M	Sell	121,946 -21,854	-15%	-$2.21M	0.08%	28
2022 Q1	$16M	Buy	+143,800	New	+$15.2M	0.1%	26

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Veritas Asset Management's MDT Position: Q2 2026 in Review

Veritas Asset Management reduced its Medtronic (MDT) stake by 41% in Q2 2026, selling an estimated $5.33M and leaving 96,690 shares worth $7.56M. The position accounts for 0.14% of the portfolio, ranked #20.

Veritas Asset Management first reported a position in MDT in Q1 2022 and has held it in 18 quarters since. The position peaked at $17.4M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Veritas Asset Management held 96,690 shares of Medtronic worth $7.56M as of Q2 2026.
Veritas Asset Management sold 66,018 Medtronic shares in Q2 2026, an estimated $5.33M.
Medtronic made up 0.14% of Veritas Asset Management's portfolio in Q2 2026, its #20 holding.
Veritas Asset Management first reported a position in Medtronic in Q1 2022 and has held it in 18 quarters since.
Veritas Asset Management's Medtronic position peaked at $17.4M in Q4 2025.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Veritas Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.